Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Study Links Serum Calcium, Prostate Cancer Death

High, but still normal, levels triple risk of aggressive disease

By Jeffrey Perkel
HealthDay Reporter


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Ankylosing Spondylitis
Baldness
Basal Cell Carcinoma
More...

Related Healthscout Videos
 border=
A Welcome Message from Survivor PJ Hamel
Smother Says "Cut!"
Maryann and Paula
When's the Next Free Mammogram Day? October 17, 2008!!!
More...

Related Animations
 border=
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Cialis
Epogen
Flomax
Iressa
More...

Related News Articles
 border=
Iressa as Good as Chemotherapy for Lung Cancer
Latin Women More Likely to Be Unhappy With Breast Cancer Treatment Decisions
ADHD Medications Don't Pose Cancer Risk
New Approach Keeps Tumor Cells From Refueling
More...

WEDNESDAY, Sept. 3 (HealthDay News) -- Men whose serum calcium levels fall within the high end of the normal range are three times more likely to develop fatal prostate cancer, a new report shows.

The results suggest the possibility of a new biomarker for aggressive prostate cancer, the researchers said. But one expert cautioned against reading too much into the study, given the relatively small number of individuals involved.

Text Continues Below



Gary Schwartz, of Wake Forest University Health Sciences in Winston-Salem, N.C., and Halcyon Skinner, of the University of Wisconsin, Madison, used data from the National Health and Nutrition Examination Survey (NHANES) and NHANES Epidemiologic Follow-up Study to determine the risk of prostate cancer among men with relatively high, but still normal, blood serum calcium readings.

Participants represented a random cross-section of American households, and they were first examined in the early 1970s. At that time, blood samples were drawn, and serum calcium levels obtained. The participants were then monitored for an average of almost 10 years. Skinner and Schwartz asked, in this population, was there any correlation between baseline serum calcium and risk of prostate cancer later in life?

"It would be the equivalent of a high school guidance counselor looking at SAT scores from students 20 years ago to see how [the scores] predict academic or business success," Schwartz explained.

In the study, 2,814 men between the ages of 24 and 77 at the time of their initial blood draw were included in the analysis, yielding 85 total cases and 25 fatal cases of prostate cancer over 46,188 person-years of follow-up.

When these cases were segregated according to the individuals' serum calcium levels, the authors found that those whose serum calcium readings during the initial blood draw fell at the highest-third of the normal range (between 9.9 mg/dL and 10.5 mg/dL) were about 2.7 times more likely to die of prostate cancer than those with readings in the lowest or middle thirds (between 9.0 mg/dL and 9.8 mg/dL).

Page:  1 | 2 | 3 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 9/3/2008

Related Links
 border=
From Healthscout's partner site on prostate, ProstateCommons.com
Prostate Check: Test yourself for symptoms online
Video: Prostate ultrasounds may save lives
Treatment: Get information about enlarged prostate treatments





SOURCES: Gary G. Schwartz, Ph.D., M.P.H., associate professor, cancer biology and epidemiology and prevention, Wake Forest University Health Sciences, Winston-Salem, N.C.; Durado Brooks, M.D., M.P.H., director, Prostate & Colorectal Cancer, American Cancer Society, Atlanta; September 2008, Cancer Epidemiology, Biomarkers & Prevention


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service